Compare · head to head
Diagnósticos da América vs Dr. Lal PathLabs
Dr. Lal PathLabs ranks higher overall — 360 rank 62 vs 51.
Diagnósticos da América leads on Value (58 vs 22), Growth (64 vs 54) and Sentiment (60 vs 47). Dr. Lal PathLabs leads on Quality (73 vs 45) and Safety (67 vs 24).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Brazil | India |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Health Care Providers & Services |
| Size | Medium | Medium |
| ISIN | BRDASAACNOR1 | INE600L01024 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 51 | 62 |
| Value | 58 | 22 |
| Quality | 45 | 73 |
| Growth | 64 | 54 |
| Safety | 24 | 67 |
| Sentiment | 60 | 47 |
| Quality details | ||
| Profitability | 37 | 92 |
| Cash Truth | 52 | 54 |
Diagnósticos da América vs FleuryDiagnósticos da América vs Hapvida Participações e InvestimentosDiagnósticos da América vs IHH HealthcareDiagnósticos da América vs Life Healthcare GroupAdd a third stock →
Full analyses: Diagnósticos da América · Dr. Lal PathLabs
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100